Learn about the latest advances in inflammatory bowel disease (IBD) and advanced endoscopic procedures from the experts of the Dr. Henry D. Janowitz Division of Gastroenterology at Mount Sinai. Ever since Mount Sinai physician Burrill Crohn, MD, and colleagues described the condition now known as Crohn’s disease, Mount Sinai gastroenterologists have been on the cutting edge of diagnosing and treating IBD and other gastrointestinal disorders. Bruce Sands, MD, MS is the Chief of the Division of Gastroenterology and Director of the Digestive Disease Institute. A longtime advocate for the continued translational research in Crohn's disease and ulcerative colitis, Dr. Sands is widely recognized for his innovative treatment of IBD and for his clinical investigations of new therapeutics. Our Susan and Leonard Feinstein IBD Clinical Center, led by Jean-Frederic Colombel, MD, and Marla Dubinsky, MD, is at the forefront of research into the causes of IBD and leads the field in clinical trials that have advanced patient care. Additionally, at our Center for Advanced Colonoscopy and Therapeutic Endoscopy at Sinai (CACTES), led by Christopher DiMaio, MD, our physicians are pioneering new tools and techniques to identify, diagnose, and treat the most complex digestive disorders.
Referring a patient is easy. Just click the “Refer a Patient Online” button.
Latest Videos| View More >
The Susan and Leonard Feinstein Inflammatory Bowel Disease Clinical Center
See what makes our Susan and Leonard Feinstein Inflammatory Bowel Disease Clinical Center unique.
An advanced radiotherapy technique called radiation segmentectomy may be effective against very early to early-stage hepatocellular carcinoma (HCC), a type of liver cancer that cannot be treated surgically or thermally.
Cholangiocarcinoma: Bridging the Gap Between the Clinic and the Laboratory
This presentation highlights the epidemiology and current management of cholangiocarcinoma, as well as future therapeutic approaches
Jerry Waye, MD Endoscopy Conference
For the past four decades, the Jerry Waye, MD, Endoscopy Conference has featured case presentations at a weekly gathering of gastroenterology fellows and clinical staff at Mount Sinai.
Pediatric Therapeutic Endoscopy Program at Mount Sinai
Dr. J. Antonio Quiros discusses the Pediatric Therapeutic Endoscopy Program at Mount Sinai
Joanne Lai, MD, Discusses the Pediatric Gastroenterology Program at Mount Sinai Doctors-Long Island
Joanne Lai, MD, discusses the range of pediatric gastroenterology services offered at Mount Sinai Doctors-Long Island.
David Dunkin, MD, Discusses Pediatric Gastroenterology Services at Mount Sinai-Brooklyn Heights
Listen as David Dunkin, MD, discusses the advanced and innovative pediatric gastroenterology care provided at Mount Sinai Doctors-Brooklyn Heights
Case Based Question & Answer Session: Liver Diseases
Case Based Question & Answer Session on Liver Pathology, Abnormal LFTs and Jaundice, Hepatitis B, Hepatitis C, Autoimmune Hepatitis, Alcoholic and Nonalcoholic Liver Disease, Cholestatic Liver Disease, Liver Tumors, Cirrhosis, Portal Hypertension ...
The Innovation Cafe Presents Trellus Health: Transforming IBD Patient Care
The founders of Trellus Health, LLC, discuss their resiliency-driven approach to inflammatory bowel disease treatment utilizing digital tools, care coordination, and support
Advanced Endoscopy and Inflammatory Bowel Disease
Christopher DiMaio, MD, discusses advanced therapeutic endoscopic procedures that can provide an alternative to surgery for gastrointestinal conditions.
COVID-19: IBD Update From the Front Lines
A new database tracks risk factors for IBD patients who have COVID-19
COVID-19: Implications on Inflammatory Bowel Disease
COVID-19: Implications on Inflammatory Bowel Disease
Colon Cancer Screening: From Molecular Genetics to Health Equity
Colon cancer screening: what to look for
Severe Acute and Necrotizing Pancreatitis: Paradigm Shifts in Management
Helping patients with pancreatitis
Understanding the Human Microbiome and its Therapeutic Potential
Understanding IBD and the microbiome
Looking Back and in the Distance: Are We on Track to Change IBD Patients' Lives
Helping patients with IBD
Recent Advances in the Diagnosis and Management of Barrett's Esophagus
Advances in Barrett's Esophagus
Breaking Down the Barriers: Disparities in Colorectal Cancer Screening in African Americans
African Americans experience low rates of colorectal cancer screening
Featured Content
Gastroenterology, GI Surgery and Liver Diseases Specialty Report 2022
Collaboration—among specialists in different disciplines, and between clinicians and bench scientists—is a hallmark of the Mount Sinai Health System and our Dr. Henry D. Janowitz Division of Gastroenterology. That approach is spotlighted ...
The Mount Sinai Hospital Included in New Ranking of Best Specialized Hospitals from Newsweek
Gastroenterology and Mount Sinai Heart are among the specialties recognized at The Mount Sinai Hospital in Newsweek’s “The World’s Best Specialized Hospitals 2021.”
COVID-19 Vaccines for IBD Patients: International Consensus
The Icahn School of Medicine at Mount Sinai was ranked No. 3 in the world in U.S. News & World Report “Best University for Gastroenterology and Hepatology.” The Seventh Annual U.S. News & World Report “Best Global Universities” rankings ...
Deirdre J. Cohen, MD, MS, an expert in pancreatic and other gastrointestinal cancers, has joined Mount Sinai Health System as Director of the Gastrointestinal Oncology Program
Vedolizumab Versus Adalimumab for Moderate to Severe Ulcerative Colitis
In the first clinical trial to evaluate two biologic therapies for moderate to severe ulcerative colitis (UC) head to head, Mount Sinai researchers found vedolizumab to be superior to adalimumab in a variety of measures.
Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis
Ustekinumab is more effective than placebo as an induction and maintenance therapy for UC.
New research in the disruptions in the GI tract of HIV-1 patients
Population analysis on IBD in Western Countries
Study of infants born to mothers with IBD
Bringing Ultrasound to the Bedside to Rapidly Diagnose and Treat IBD
The Susan and Leonard Feinstein Inflammatory Bowel Disease Clinical Center at Mount Sinai is the only center in the country that is currently using ultrasound to monitor inflammation in inflammatory bowel disease patients.
Carving Out a New Care Pathway for Patients With IBD and Arthritis
A collaborative model between Gastroenterology and Rheumatology in the Department of Medicine at Mount Sinai is providing patients with IBD and arthritis a level of care few clinics in the world can offer, and researchers with a springboard ...
Providing Much-Needed Support for Women After J-Pouch Surgery
Mount Sinai Health System, which pioneered and continues to refine the technique of J-pouch surgery, has now created a Comprehensive Pouch Program to closely monitor patients after surgery, ensuring continuous, hands-on care designed to ...
Mount Sinai Introduces Two Novel Endoscopy Procedures
Mount Sinai’s interventional endoscopy team continues to lead the field in innovation with the recent introduction of two novel procedures that are dramatically advancing treatment for patients with achalasia, necrotizing pancreatitis, ...
Genetic Studies Identify New Pathways in Inflammatory Bowel Disease
Two new Mount Sinai studies have defined novel approaches for treating Crohn’s disease and ulcerative colitis (UC).
New Center of Excellence Focuses on NASH Treatment and Research
The Mount Sinai Division of Liver Diseases has built on its nationally recognized expertise in fibrosis and fibrotic pathways to create the NASH Center of Excellence, concentrating under one umbrella a rich diversity of clinical and research ...
Gender Inequities in Gastroenterology Spur Efforts for Change
While gastroenterology is historically a male-dominated field, the ranks of female professionals are growing.
Intestinal Ultrasound Ushers In New Era of IBD Treatment
Intestinal ultrasound to monitor ulcerative colitis and Crohn's disease has become the standard of care in Canada and many parts of Europe, but has never gained a foothold in the United States.
Registry Tracks How IBD Drugs Interact With COVID-19
A research database known as SECURE-IBD provides a quick and robust source of information to clinicians around the world about the use of IBD therapies like corticosteroids and the widely prescribed tumor necrosis factor (TNF) antagonists ...
Intestinal Study Yields Insights Into Persistence of SARS-CoV-2
SARS-CoV-2 has a spike protein that tethers itself to angiotensin converting enzyme 2 (ACE2) to gain entry to cells, and the intestinal tract has the highest expression of ACE2 in the body—even higher than in the lungs.
Novel Understanding of Fecal Microbiota Could Make Transplantation Safer and More Precise
Researchers used whole-genome sequencing to identify 42 species of fecal microbiota that were especially likely to engraft successfully.
Gastroenterology, GI Surgery and Liver Diseases Specialty Report 2021
We launched a database called SECURE-IBD that has already yielded the insight that TNF antagonists appear to be a low-risk IBD therapy where COVID-19 is concerned, and another study, called ICARUS, intended to explore the seroprevalence ...